Friday, 8 April 2011

Biotechnology company aids in mesothelioma research

Because the search for a cure of mesothelioma continues, new innovations in the field of biology, medicine and technology are promising. Sigma Life Sciences is a company to add their expertise to the fight against the deadly mesothelioma and other cancers. Their goal to "provide researchers with cellular models of cancer that is expected to improve drug development for personalized medicine", Sigma Life Science provides an important role in research in mesothelioma.

Sigma Life Sciences manufactures and supplies products for all areas of scientific study and research. From animal models genetically modified cell lines, Sigma Life Science provides ready-to-use and customized solutions for scientific tests. Their new line of genetically modified tumor cells is of particular interest for mesothelioma researchers.

Mesothelioma is a rare tumor that affects about you thousand Americans each year. E 'caused by asbestos, a chemical WHO has labeled as a type 1 carcinogen. use of asbestos has been reduced significantly in many countries but is still used in developing land for construction and manufacturing. The total number of mesothelioma cases is estimated at ten thousand and is expected to be increasing.

Once the asbestos fibers are inhaled, they can begin to develop cancer of the lining of the lungs and other body cavity. irregularly shaped tumors to grow for decades without showing signs or symptoms. Most patients have no idea mesothelioma being sick up to twenty to fifty years after initial exposure to asbestos. Although there are mesothelioma treatment options, there is no known cure. Patient's average life expectancy of eighteen months after being diagnosed with mesothelioma.

Using their own instrument, CompoZr, Sigma Life Science aid in the development of personalized medicine through the "target validation, identification of the mechanical action of drugs and investigations of disease development, the progression and remission. "Sigma Life Science CompoZr allowed to produce" knockout "models. The process used for the mice they won the silver star of" Top Ten Innovations of 2010 "by the magazine Scientist.

The term "knockout" refers to a process that renders a gene from a sample of cells irrelevant and removed, or "knockout" compared to cells in normal individuals. Edward Weinstein, director of the Center for the essay Sigma Life Science Laboratories SAGE, said knockout technology will be "scientists powerful new tools to study human diseases."

Sigma Life Sciences will bring its new range of models of genetically modified cells of colon-rectum and lung.